Abiopharma

Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering

NeuroSense Reports Positive Biomarker Findings from Phase 2 RoAD Proof-of-Concept Study of PrimeC in Alzheimer's Disease

Ernexa Therapeutics Launches CEO Corner to Provide Deeper Insights into Company Progress, Scientific Strategy and Vision for Patients

Trust Stamp announces the closing of $5.51m financing and addresses short-selling

Terreno Realty Corporation Announces Lease in Hayward, CA

PitchBook Expands Premium AI Integrations with Microsoft 365 Copilot and Copilot in Excel

Trustee report for holders of BONDS 2 during the period from 30.6.25 to 31.12.25, Mishmeret

AV Appoints William J. Lynn III to Board of Directors

Trustee report for 2025 for holders of BONDS A, Mishmeret

CoStar Group Stockholders Overwhelmingly Reelect Director Nominees and Support Say-on-Pay at Annual Meeting of Stockholders